LG Healthcare Financials

DOCT Etf  CHF 11.60  0.38  3.17%   
You can make use of LG Healthcare Breakthrough fundamental data analysis to find out if markets are at this moment mispricing the entity. We are able to interpolate and break down seven available financial indicators for LG Healthcare, which can be compared to its peers in the sector. The etf experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of LG Healthcare to be traded at ₣11.14 in 90 days. Key indicators impacting LG Healthcare's financial strength include:
Net Expense Ratio
0.0049
3 y Sharp Ratio
0.16
  
The data published in LG Healthcare's official financial statements typically reflect LG Healthcare's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving LG Healthcare's quantitative information. For example, before you start analyzing numbers published by DOCT accountants, it's essential to understand LG Healthcare's liquidity, profitability, and earnings quality within the context of the LGIM Managers (Europe) Limited space in which it operates.
Please note, the imprecision that can be found in LG Healthcare's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of LG Healthcare Breakthrough. Check LG Healthcare's Beneish M Score to see the likelihood of LG Healthcare's management manipulating its earnings.

LG Healthcare Etf Summary

LG Healthcare competes with Vanguard FTSE, and UBS ETF. The investment objective of the LG Healthcare Breakthrough UCITS ETF is to provide exposure to the global healthcare technology industry. Robo Healthcare is traded on Switzerland Exchange in Switzerland.
InstrumentSwitzerland Etf
ExchangeSIX Swiss Exchange
ISINIE00BK5BC677
RegionOthers
Investment IssuerOthers
Etf FamilyLGIM Managers (Europe) Limited
Fund CategoryOthers
Portfolio ConcentrationOthers
BenchmarkDow Jones Industrial
CurrencyCHF - Swiss Franc

DOCT Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining LG Healthcare's current stock value. Our valuation model uses many indicators to compare LG Healthcare value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LG Healthcare competition to find correlations between indicators driving LG Healthcare's intrinsic value. More Info.
LG Healthcare Breakthrough is rated below average in one year return as compared to similar ETFs. It also is rated below average in three year return as compared to similar ETFs reporting about  0.21  of Three Year Return per One Year Return. The ratio of One Year Return to Three Year Return for LG Healthcare Breakthrough is roughly  4.79 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LG Healthcare's earnings, one of the primary drivers of an investment's value.

LG Healthcare February 8, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of LG Healthcare help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of LG Healthcare Breakthrough. We use our internally-developed statistical techniques to arrive at the intrinsic value of LG Healthcare Breakthrough based on widely used predictive technical indicators. In general, we focus on analyzing DOCT Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build LG Healthcare's daily price indicators and compare them against related drivers.

Other Information on Investing in DOCT Etf

LG Healthcare financial ratios help investors to determine whether DOCT Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in DOCT with respect to the benefits of owning LG Healthcare security.